Mammalian Bax triggers apoptotic changes in yeast  by Ligr, Martin et al.
Mammalian Bax triggers apoptotic changes in yeast
Martin Ligra, Frank Madeob, Eleonore Froºhlichc, Wolfgang Hilta, Kai-Uwe Froºhlichb,
Dieter H. Wolfa;*
aInstitut fuºr Biochemie, Universitaºt Stuttgart, Pfa¡enwaldring 55, 70569 Stuttgart, Germany
bPhysiologisch-Chemisches Institut, Universitaºt Tuºbingen, Hoppe-Seyler-StraMe 4, 72076 Tuºbingen, Germany
cAnatomisches Institut, Universitaºt Tuºbingen, Oº sterbergstraMe 3, 72074 Tuºbingen, Germany
Received 4 September 1998
Abstract Apoptosis is co-regulated by the conserved family of
Bcl-2-related proteins, which includes both its agonists (Bax) and
antagonists (Bcl-XL). A mutant strain of the yeast Saccha-
romyces cerevisiae has been shown to express all morphological
signs of apoptosis. Overexpression of Bax is lethal in S.
cerevisiae, whereas simultaneous overexpression of Bcl-XL
rescues the cells. We report that overexpression of mammalian
Bax in a S. cerevisiae wild type strain triggers morphological
changes similar to those of apoptotic metazoan cells : the loss of
asymmetric distribution of plasma membrane phosphatidylserine,
plasma membrane blebbing, chromatin condensation and mar-
gination, and DNA fragmentation. Simultaneous overexpression
of Bcl-XL prevents these changes. We demonstrate that Bax
triggers phenotypic alterations in yeast strongly resembling those
it causes in metazoan apoptotic cells.
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1. Introduction
Apoptosis, a form of programmed cell death, is a part of
normal development and homeostasis in metazoans. Break-
down of its regulation leads to a variety of diseases such as
cancer, and neurodegenerative and autoimmunity disorders
[1]. Morphologically apoptosis is de¢ned by the loss of asym-
metric distribution of plasma membrane phospholipids [2],
condensation and margination of chromatin, DNA fragmen-
tation [3], plasma membrane blebbing, and ¢nally the break-
age of the cell into membrane-enclosed apoptotic bodies [4].
This process is co-regulated by the conserved family of Bcl-2-
related proteins, which includes both agonists (Bax, Bak, Bad,
Bcl-XS) and antagonists (Bcl-2, Bcl-XL) of apoptosis [5]. The
decision on entry to apoptosis is achieved by direct interaction
between these two groups. This interplay may regulate the
constitution of channels in intracellular membranes and inter-
action with additional proteins [6]. The ultimate purpose of
these interactions in mammalian cells is to control the activa-
tion of caspases. These are a group of cysteine proteases
thought to be the actual e¡ectors of apoptosis [7], which
cleave speci¢c target substrates [8].
A model has emerged recently, according to which the pro-
apoptotic members of the Bcl-2 family trigger cell death by
facilitating the release of cytochrome c from mitochondria.
Cytochrome c then binds to CED-4/Apaf-1, an adaptor pro-
tein which in turn processes caspase-9/CED-3 to its active
form. Negative apoptotic regulators of the Bcl-2 family are
suggested to act at two levels. They are able to block release
of cytochrome c, or prevent the activation of the caspase
cascade by binding to CED-4/Apaf-1 [9].
While studying the interaction of Bax with other Bcl-2-like
proteins, Reed and colleagues observed that its overexpression
inhibited the growth of the yeast Saccharomyces cerevisiae, a
phenotype which could be suppressed by simultaneous over-
expression of antiapoptotic members of the Bcl-2 family
[10,11]. This no-growth phenotype was demonstrated to be
caused by cell death, and not simply by growth arrest [12].
These observations led to the key question: is the death trig-
gered in yeast by metazoan apoptotic regulators equivalent to
apoptosis? The ensuing studies gave equivocal results [13^15].
Recently a mutation in an indigenous S. cerevisiae protein
Cdc48p has been described, which caused a set of phenotypic
changes in yeast normally de¢ning apoptosis in metazoan cells
[16]. We therefore asked if overexpression of the mammalian
protein Bax leads to a similar apoptotic phenotype in this
unicellular eukaryote.
2. Materials and methods
2.1. Yeast strains and plasmids
Plasmids pSD10.a-Bax and pSD10.a-Bcl-XL [17] contain a cDNA
fragment of the respective gene under the control of a hybrid GAL1-
10/CYC1 promoter in a pRS316-based vector with URA3 marker
[18]. The marker in pSD10.a-Bcl-XL was changed to LEU2, yielding
pL009. Wild type S. cerevisiae strain WCG4 (MATK his3-11,15 leu2-
3,112 ura3) was transformed with plasmids pSD10.a-Bax (CEN6,
URA3), pL009 (CEN6, LEU2), and control vectors pRS315
(CEN6, LEU2) and pRS316 (CEN6, URA3) [19]. Strains were pre-
grown in synthetic complete (SC) medium (0.67% nitrogen base with-
out amino acids, amino acids and nucleotide bases) lacking leucine
and uracil, and containing 2% glucose as the carbon source at 30‡C to
a cell density of about 0.5U106/cm3. To induce the expression of Bax
and Bcl-XL, cells were washed three times and resuspended in SC
medium with 2% galactose instead of glucose. Cells with control plas-
mids and with Bax plus Bcl-XL plasmids were diluted so that the cell
density at the end of treatment was about 0.5U106/cm3. The cell
density of the culture of cells expressing Bax did not change within
22 h of further incubation.
To visualize nuclei the cells were incubated with 1 Wg/cm3 DAPI in
HEPES bu¡er (10 mM HEPES/NaOH bu¡er pH 7.4, 140 mM NaCl,
2.5 mM CaCl2) for 20 min, washed three times with HEPES bu¡er,
and examined under the £uorescence microscope.
2.2. Annexin V staining
Externalization of PS was detected as described previously [16].
Cells were resuspended in digestion bu¡er (1.2 M sorbitol, 0.5 mM
MgCl2, 35 mM PO334 , pH 6.8) and incubated for 2 h at 30‡C with 15
U/cm3 zymolyase 100T (Seikagaku Corporation, Tokyo, Japan) and
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5.5% glusulase (NEN, Boston, MA). After cell wall digestion cells
were washed in binding bu¡er containing sorbitol (1.2 M sorbitol,
10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2).
The protoplasts were resuspended in 38 Wl of binding bu¡er and in-
cubated with 2 Wl annexin-FITC (Clontech) and 2 Wl PI (500 Wg/ml) in
the dark for 20 min at room temperature. Cells were mounted on a
slide and examined under the £uorescence microscope.
2.3. Electron microscopy
Yeast cells were prepared for electron microscopy as described pre-
viously [16]. Cells were ¢xed with phosphate-bu¡ered glutardialde-
hyde, cell walls were removed, and the cells were post¢xed with os-
mium tetroxide and uranyl acetate and dehydrated as described by
Byers and Goetsch [20] for stationary-phase cells. Following the 100%
ethanol washes, cells were washed with 100% acetone, in¢ltrated with
50% acetone/50% Epon for 30 min and with 100% Epon for 20 h.
Cells were transferred to fresh 100% Epon and incubated at 56‡C for
48 h before cutting thin sections and staining with lead acetate.
2.4. TUNEL staining
A previously described protocol for TUNEL detection of frag-
mented nuclear DNA in yeast [16] was used with small changes. Cells
were ¢xed in 3.7% formaldehyde for 1 h and the cell walls were
removed as described above. The protoplasts were then applied to
polylysine-coated slides. In Situ Cell Death Detection Kit POD
(Boehringer Mannheim, Mannheim, Germany) was used according
to the manufacturer’s instructions. After mounting the coverslip
with a drop of Kaiser’s glycerol gelatin (Merck, Darmstadt, Germany)
the cells were examined under the light microscope.
3. Results
3.1. Bax causes the loss of plasma membrane asymmetry
in yeast
Lipid composition of the inner and outer lea£ets is di¡erent
in most biological membranes [21], including the yeast plasma
membrane [22]. This asymmetry is maintained by an enzy-
matic activity [23,24] linked in both mammalian and yeast
cells to ABC transporters [25,26]. In cells undergoing apopto-
sis the asymmetry of the plasma membrane is lost and phos-
phatidylserine (PS) is exposed on the cell surface [2]. In mam-
malian cells, this process is enhanced by the loss of the
aminophospholipid translocase activity and the presence of
extracellular calcium [27].
To test if overexpression of Bax in budding yeast leads to
the loss of membrane asymmetry and the exposure of PS on
the cell exterior, protoplasts were incubated with FITC-la-
beled annexin V, a PS binding protein. In parallel, the intact-
ness of the protoplasts was assessed by their ability to exclude
propidium iodide (PI). After 6 h of galactose induction the
binding of annexin V was visible in some cells as punctate
structures at the plasma membrane (Fig. 1a), after 15 h about
10% of the cells showed green halos surrounding the cells
(Fig. 1c,e).
Exposure of PS on the cell surface accompanying the Bax-
induced death of yeast may be due to loss of the putative
aminophospholipid translocase activity in a process similar
to PS exposure in apoptotic mammalian cells. In mammalian
systems the display of PS on the cell surface serves as a rec-
ognition signal for removal of apoptotic cells by macrophages
[28]. The presence of this phenomenon already in yeast indi-
cates a more fundamental connection to apoptosis.
3.2. Overexpression of Bax leads to chromatin condensation
and plasma membrane blebbing
Bax expression induced changes of nuclear morphology of
yeast cells were followed by diaminophenylindole (DAPI)
staining of DNA. After overexpression of Bax for 15 h about
20% of the cells showed abnormal nuclear morphology: alter-
ations ranged from accumulation of DAPI staining in ring-
like structures (Fig. 2e), presence of multiple DAPI-stained
regions within the area of the nucleus (Fig. 2c), to the appear-
ance of multiple stained regions within a single cell (Fig. 2a).
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Fig. 1. Overexpression of Bax leads to the exposure of phosphatidylserine on the outer lea£et of the plasma membrane of S. cerevisiae cells.
Cells transformed with control plasmid pRS315 plus plasmid pSD10.a-Bax carrying Bax (a^f), control plasmids pRS315 and pRS316 (g), or
plasmids pSD10.a-Bax and pL009 carrying Bcl-XL (h). Cells were probed with FITC-annexin V conjugate and propidium iodide after 6 h (a,b)
or 15 h (c^h) of induction on galactose medium. Figures (a,b), (c,d), (e,f) show the same cells examined with the FITC (a,c,e,g,h) and PI
(b,d,f) ¢lters. Cells binding annexin V exclusively on the outer lea£et of the plasma membrane are recognized by a green halo and no orange
staining.
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Electron microscopic examination of same culture as used for
DAPI staining revealed the presence of nuclear regions of
condensed chromatin, often located at the periphery of the
nucleus (Fig. 3c,d). These alterations in the nuclear morphol-
ogy are reminiscent of the changes observed in apoptotic
mammalian cells [29], and very similar to those described in
the yeast cdc48S565G mutant [16].
Chromatin condensation as a result of expression of Bax or
its homologue Bak had been observed in Schizosaccharomyces
pombe [14,15]. However, changes in nuclear morphology re-
ported by these groups were accompanied by extensive vacuo-
lization, perhaps induced by prolonged expression of pro-
apoptotic proteins (for up to 48 h). This may mirror a situa-
tion during terminal stages of mammalian apoptosis when the
cellular content is being disposed of. On the other hand, when
ced-4 was expressed in S. pombe for only 12 h, extensive
chromatin condensation and disruption of the nucleus took
place in the absence of any vacuolization [30]. Under our
experimental conditions no vacuolization was observed.
Only some degree of plasma membrane blebbing occurred
(Fig. 3c), paralleling the situation during the onset of mam-
malian apoptosis.
3.3. Nuclear DNA is fragmented in yeast overexpressing Bax
To examine if the alterations in nuclear morphology are
also accompanied by changes in the physical intactness of
DNA, we inspected the Bax expressing cells by the TUNEL
(terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labeling) assay [31]. During this procedure terminal
deoxynucleotidyl transferase attaches FITC-conjugated
dUTP tails to free 3P ends of DNA in a template-independent
fashion. With the breakage of DNA the number of free 3P ends
increases signi¢cantly, giving rise to a stronger TUNEL
staining in the a¡ected nuclei.
When performing the TUNEL assay, approximately 30% of
the Bax-expressing cells showed staining in their nuclei (Fig.
4a), indicating the presence of damaged DNA. A similar rate
of TUNEL staining had been found in the exponentially
growing cdc48S565G mutant [16]. In mammalian cells the cleav-
age of DNA as a result of Bax-induced apoptosis is thought
to be dependent on the activity of caspases [32] and caspase-
activated DNase(s) [8]. In bacteria, on the contrary, the ex-
pression of Bax led to DNA damage in the absence of casp-
ases [33], as in our yeast system.
3.4. Bcl-XL prevents the appearance of Bax-induced
apoptotic phenotypes in yeast
Bcl-XL prevents Bax-induced cell death in both metazoan
and yeast cells. We observed that co-expression of Bax and
Bcl-XL not only rescues the yeast cells from Bax-induced cell
death, but also prevents the characteristic phenotypes that
accompany it. We observed no binding of annexin V to the
intact protoplasts (Fig. 1h). The morphology of the nucleus
examined by DAPI staining appeared wild type-like (Fig. 2i),
as well as the appearance of the nuclei under the electron
microscope (Fig. 3b). In addition no signi¢cant TUNEL
staining was detected in the nuclei of these cells (Fig. 4c).
These data show that the phenotypes associated with Bax
overexpression in yeast are tightly linked with its killing func-
tion, since co-expression of its antagonist, Bcl-XL, eliminated
both the Bax-induced cell death and its associated phenotypes.
4. Discussion
S. cerevisiae cells overexpressing the mammalian apoptotic
stimulator Bax display a series of changes, identical to mor-
phological markers de¢ning apoptosis in mammalian cells.
Early during Bax induction the plasma membrane of the cells
apparently loses its asymmetry as PS is exposed on the surface
of the cell. Chromatin undergoes condensation and margin-
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Fig. 2. Nuclei of cells overexpressing Bax show abnormal morphology. Yeast cells containing the control plasmid pRS315 plus plasmid
pSD10.a-Bax carrying Bax (a^f), control plasmids pRS315 and pRS316 (g,h), or plasmids pSD10.a-Bax and pL009 carrying Bcl-XL (i,j) were
stained with DAPI after 15 h of induction on galactose. Figures (a,b), (c,d), (e,f), (g,h), (i,j) show the same cells examined with the DAPI ¢lter
(a,c,e,g,h,i) and Nomarski optics (b,d,f,h,j).
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ation, and nuclear DNA is fragmented. Some degree of plas-
ma membrane blebbing was observed as well. These altera-
tions are absent in the control cells cultivated under identical
conditions, as well as in the cells where the lethal e¡ect of Bax
expression was compensated by co-expression of the mamma-
lian apoptotic inhibitor Bcl-XL. In a screen for genes involved
in the putative apoptotic pathway in yeast only 9% of the
clones that could be induced to undergo cell death showed
positive annexin V and TUNEL staining (M. Ligr and F.
Madeo, unpublished observations). Therefore the observed
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Fig. 4. The nuclei of yeast cells overexpressing Bax contain fragmented DNA. Yeast cells transformed with control plasmid pRS315 plus plas-
mid pSD10.a-Bax carrying Bax (a), control plasmids pRS315 and pRS316 (b), and plasmids pSD10.a-Bax and pL009 carrying Bax and Bcl-XL
(c) were induced on galactose for 15 h. Fragmentation of nuclear DNA was detected with the TUNEL test (formation of black-stained nuclei).
Fig. 3. Overexpression of Bax results in chromatin margination and condensation, as well as blebbing of the yeast plasma membrane. Electron
micrographs of yeast cells transformed with control plasmids pRS315 and pRS316 (a), plasmids pSD10.a-Bax and pL009 carrying Bax and
Bcl-XL, respectively (b), or with control plasmid pRS315 plus plasmid pSD10.a-Bax carrying Bax (c,d). Cells were induced on galactose for 15
h. Arrows point to regions of nuclei with condensed and marginalized chromatin, arrowheads mark the blebbing of the plasma membrane. N,
nucleus; V, vacuole.
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apoptotic phenotypes are not likely to be just general features
of dying yeast. We do not see any connection among the
observed phenotypes of Bax-killed yeast cells other than their
link to metazoan apoptosis.
The e¡ects of Bax expression in S. pombe and S. cerevisiae
reported previously were based largely on electron microscopy
and led to conclusion that Bax-induced cell death in yeast
di¡ers from apoptosis [13^15]. In contrast, using a compre-
hensive set of tests for morphological markers of apoptosis,
we show that Bax-induced cell death in budding yeast has an
apoptotic character.
The apoptotic program in metazoan cells is thought to de-
pend on the proteolytic action of caspases [7]. The complete
sequence of the yeast genome [34] con¢rmed the absence of
homologues of known apoptotic regulators of the Bcl-2 fam-
ily, as well as of caspases in S. cerevisiae. Interestingly, Bax is
able to kill mammalian cells in the absence of caspase activity
as well [32]. In this case the lethal e¡ect of Bax is accompanied
by the production of reactive oxygen species.
These ¢ndings point to the presence of a pathway respon-
sible for execution of cell death common in yeast and meta-
zoan cells. This putative pathway could function in parallel
with the well studied caspase-dependent pathway in multicel-
lular eukaryotes, or it could be a basic framework upon which
the caspase pathway developed.
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